Search Medical Condition
Please enter condition
Please choose location from dropdown

Rockville Centre, New York Clinical Trials

A listing of Rockville Centre, New York clinical trials actively recruiting patient volunteers.

RESULTS

Found (862) clinical trials

Feasibility Information for Timely Completion of Neuroimaging Data Collection

This study will recruit approximately 5,000 patients with histologically confirmed cancer who have successfully completed MSK-IMPACT panel testing and collect information about tumor genetic results and patient exercise behavior history. The purpose of the study is to create a registry to collect exercise behavior history in patients who had IMPACT ...

Phase N/A

0.0 miles

Learn More »

Long-Term Quality of Life in Patients With Metastatic Melanoma Treated With Checkpoint Inhibitors

To identify and describe long-term quality of life (QOL) issues in patients with metastatic melanoma treated with checkpoint inhibitors who achieved cancer control for a minimum of 12 months and remain on maintenance checkpoint inhibitor therapy.

Phase N/A

0.0 miles

Learn More »

PSMA PET Imaging of Recurrent Prostate Cancer

The purpose of this study is to see if a new diagnostic research agent named 68Ga-HBED-CC-PSMA can show prostate cancer on a PET/CT scan that cannot be seen on other standard imaging even when the PSA levels are very low.

Phase

0.0 miles

Learn More »

Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors

PRIMARY OBJECTIVES: I. To evaluate the safety and tolerability of the combination of navitoclax and vistusertib in patients with advanced solid tumors. (Phase I) II. To determine the maximum tolerated dose (MTD), dose limiting toxicities (DLT), and recommended phase 2 doses (RP2D) of navitoclax and vistusertib. (Phase I) III. To ...

Phase

0.0 miles

Learn More »

A Study of Nivolumab in Selected Uterine Cancer Patients

The purpose of this study is to test the safety of nivolumab and find out what affects, if any, nivolumab has on people and their risk of uterine cancer. The investigators also want to find out what effects, good or bad, nivolumab has on the patient and their cancer.

Phase

0.0 miles

Learn More »

Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control

The purpose of this study is to compare using bupivacaine (a numbing medicine) along with the usual medications for post-operative pain control to using the usual medications for post-operative pain control alone. The addition of bupivacaine to the usual pain medications could better manage pain immediately after surgery. This study ...

Phase

0.0 miles

Learn More »

Major Radiation Reduction for HPV+ Oropharyngeal Carcinoma

The purpose of this study is to demonstrate that participants with HPV positive and hypoxia negative T1-@N / 1-2b oropharyngeal squamous cell carcinoma receiving a major de-escalated radiation therapy with 2 cycles of standard chemotherapy is not inferior to comparable subjects treated with the current standard chemoradiation.

Phase

0.0 miles

Learn More »

Proton Re-Irradiation for Recurrent Head and Neck Cancer

The purpose of this study is to evaluate the tumor control and the side effects of using proton therapy for head and neck cancer that has come back.

Phase

0.0 miles

Learn More »

Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer

This is a phase I study. The purpose of this study is to test the safety of the study drug neratinib in combination with a standard chemotherapy drug called capecitabine at different doses to find out what effects, if any, it has on people. Capecitabine (Xeloda) is approved by the ...

Phase

0.0 miles

Learn More »

The Study of Bendamustine Rituximab Ibrutinib and Venetoclax in Relapsed Refractory Mantle Cell Lymphoma

The purpose of this study is to test the safety of Venetoclax in combination with FDA approved treatments Bendamustine, Rituximab and Ibrutinib (BR-I). This study will examine the effects Venetoclax has on participants when it is given in combination with BR-I.

Phase N/A

0.0 miles

Learn More »